TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: reductions in secondary conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQoL symptom days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvements in healthy lifestyle behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: surgical incision size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: scar satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: return to 100% recovery time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Weight loss ≥10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time spent drinking
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: cell hydration status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: verbal IQ
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: overall IQ
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of cerebral palsy
Endpoint domain: Adverse events/effects
Primary endpoint: SPP (Surgical Pain Proportion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Pcuff determinations in the safety range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of ventilator-associated pneumonia (VAP)
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of women reporting moderate to severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum ketone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: core temperature decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lp(a) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of OSAS or snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased mortality in the placebo group
Endpoint domain: Mortality/survival
Primary endpoint: Plasminogen levels decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma D-dimer levels increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: meaning in life/peace
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survival rate of FRP and PP groups
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients requiring enteral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first successful shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: treatment response rates for symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: McCoy index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in observed dyskinesia ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BP difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Misdiagnosis rate of systolic hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: Misdiagnosis rate of diastolic hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of reporting of CONSORT items
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Decrease in QHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Control of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global CIU status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients requiring rescue cranioplasty
Endpoint domain: Adverse events/effects
Primary endpoint: Total hospital healthcare costs
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Culturable bacteria presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Numbers of exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intestinal mycetes overgrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: systemic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Repeatability of ocular biometry measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days missed of school due to illness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Antioxidant status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased DHV diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Eruption area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TEWL reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative sensitivity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative stone-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: volume of extracted stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximal interincisal opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diet scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight of the patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 60-day survival rates
Endpoint domain: Mortality/survival
Primary endpoint: successful weaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MID increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protrusion values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laterality values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea/vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: total number of errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the plasma concentration‐time curve (AUCtau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality rate on d.28
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of erosions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of normal oesophageal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of infants surviving until discharge
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of severe pain complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of headache complications
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment engagement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Confidence in answering
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Understanding of the topic
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: total three nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of ketobemidone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intraocular pressure at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Weight change trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of pneumothoraces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of knee extensors on the operated side
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: FIM scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Necroinflammatory score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrosis score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first adequate relief from daytime GERD-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first adequate relief from night-time GERD-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulatory blood pressure variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Echo left ventricular mass reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stunting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attendance at ≥1 growth monitoring session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mothers' knowledge on importance of GM
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: total voided volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lateral center‐edge angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acetabular index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femoral head extrusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified HHSs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip abductor impulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total scores on the CRP assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Common femoral vein area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: graft function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: reduction in treatment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Community support services usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: complete bone repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg wound complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymphocyte mean number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma Lp(a) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean migraine headache frequency per 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients showing a 50% or greater reduction in migraine headache frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional restriction reported by patients
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sperm number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ART pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adenosine, iNOS, and VEGF immunoexpression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time to recovery of TOF ratio to 0.8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of neurologic injury
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative motor strength scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Permanent neurologic deficit preventing ambulation
Endpoint domain: Mortality/survival
Primary endpoint: permanent neurologic morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of neurologic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Foley catheter dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voiding trial success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical inflammation findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative inotropic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary remodeling slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maximal workload (WMAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO(2)MAX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cost of providing humidification
Endpoint domain: Resource use
Primary endpoint: IL-6 concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hsCRP concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: tuberculosis or death
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in low-density lipoprotein (LDL) cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reported weight accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported BMI accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: guideline-concordant care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: patient-PCC agreement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: undergo at least 1 UDT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUC for the cornea after drop application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for the cornea after mist application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for the anterior chamber (AC) after drop application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for the anterior chamber (AC) after mist application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death plus nonfatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Skin conductance changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS alertness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association of vitamin D pathway SNPs with prostate cancer risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Association of low 25(OH)D metabolism score with prostate cancer grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in diameter and base curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lens induced staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to Highly Active Antiretroviral Therapy (HAART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of complete chest relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spirometry test quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global QoR‐40 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of reulceration
Endpoint domain: Adverse events/effects
Primary endpoint: radial-cephalic arteriovenous fistula failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recurrences of venous thromboembolism
Endpoint domain: Mortality/survival
Primary endpoint: Major, minor, or fatal bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: rectal bleeding improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: recurrence of febrile urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of menstrual flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative increase in 1RM of full squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume increase of knee extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Volume increase of adductor and gluteus maximus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Positive-predictive value of self-reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent sensitivity of CR and self-reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of gabapentin
Endpoint domain: Adverse events/effects
Primary endpoint: Homologous transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in VMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADMA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary endothelial vasomotor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Discharge with sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean DIS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chance of being on treatment at week-12
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: major adverse cardiac and cerebral events
Endpoint domain: Mortality/survival
Primary endpoint: rate of access-site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Melanoma-specific CD8(+) T-cell response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: disappearance rate of symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Nursing exam score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of fails in the Clinical Nursing exam
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: degree of narrowing of the operated vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: episodes of acute cerebral circulation impairment
Endpoint domain: Adverse events/effects
Primary endpoint: 8-year risk for colorectal cancer (CRC)
Endpoint domain: Mortality/survival
Primary endpoint: excess 30-day risk for any adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: CDI-2 score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transiently painful enteritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean post-test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peritoneal permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentrations of cytokines/prostanoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Outdoor walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cost reductions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of heel pain due to calcaneal apophysitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median visual analog scale pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative foreign body sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of cumulative complications
Endpoint domain: Adverse events/effects